Literature DB >> 2989145

The relative prognostic significance of nucleolar morphometry in invasive ductal breast cancer.

J P Baak.   

Abstract

In a group of 65 patients with invasive ductal breast cancer with adequate follow-up for at least 5 years, the prognostic significance of nucleolar area morphometry was investigated. In general, non-survivors have larger and more pleomorphic nucleoli. A value of the standard deviation of the nucleolar area above 2.49 micron2 was almost exclusively found in non-survivors. This is the more interesting because several of these patients had a low mitotic activity index and small tumours, some of these having negative lymph nodes. Without nucleolar morphometry these patients would have been included in a favourable prognosis group. Although the sensitivity of nucleolar morphometry is low, the method can be used as an additional prognostic indicator. This is more important as nucleoli can in principle be automatically measured with digital image processing computers.

Entities:  

Mesh:

Year:  1985        PMID: 2989145     DOI: 10.1111/j.1365-2559.1985.tb02826.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Nucleolar function and size in cancer cells.

Authors:  M Derenzini; D Trerè; A Pession; L Montanaro; V Sirri; R L Ochs
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

2.  Prognostic value of nucleolar morphometric variables in cytological breast cancer specimens.

Authors:  P J van Diest; J Mouriquand; N W Schipper; J P Baak
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

3.  Relationship between interphase AgNOR distribution and nucleolar size in cancer cells.

Authors:  M Derenzini; F Farabegoli; D Trerè
Journal:  Histochem J       Date:  1992-12

4.  Screen-detected breast cancers have a lower mitotic activity index.

Authors:  R P Groenendijk; P Bult; L Tewarie; P G Peer; R F van der Sluis; T J Ruers; T Wobbes
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.